Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with HEV-induced liver failure
Authors:
Open Access
- 9 January 2022
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-9
Abstract
Background: Viral hepatitis E clinically ranges from self-limiting hepatitis to lethal liver failure. Oxidative stress has been shown to mediate hepatic inflammation during HBV-induced liver failure. We investigated whether a biomarker of oxidative stress may be helpful in assessing severity and disease outcomes of patients with HEV-induced liver failure. Methods: Clinical data were obtained from patients with HEV-induced acute viral hepatitis (AVH, n = 30), acute liver failure (ALF, n = 17), and acute-on-chronic liver failure (ACLF, n = 36), as well as from healthy controls (HC, n = 30). The SOD and HMGB1 levels were measured in serum by ELISA. HL-7702 cells were cultured and stimulated by serum from HEV-infected patients or by HMGB1; oxidative status was investigated by CellROX and apoptosis was investigated by flow cytometry. Results: Patients with HEV-induced liver failure (including ALF and ACLF) showed increased SOD levels compared with HEV-AVH patients and healthy controls. SOD levels > 400 U/mL were associated with a significantly higher risk of mortality in HEV-ALF and HEV-ACLF patients. Serum from HEV-infected patients led to ROS accumulation, HMGB1 secretion, and apoptosis in HL-7702 cells. Antioxidant treatment successfully inhibited HEV-induced HMGB1 secretion, and HMGB1 promoted apoptosis in HL-7702 cells. Conclusion: HEV increased oxidative stress in the pathogenesis of HEV-induced hepatic diseases. Early testing of serum SOD may serve as a predictor of both HEV-ALF and HEV-ACLF outcomes. Moreover, development of strategies for modulating oxidative stress might be a potential target for treating HEV-induced liver failure patients.Keywords
Funding Information
- National Natural Science Foundation of China (81800548)
This publication has 26 references indexed in Scilit:
- Protective Role of Sirtuin3 (SIRT3) in Oxidative Stress Mediated by Hepatitis B Virus X Protein ExpressionPLOS ONE, 2016
- Hepatitis E virus infection and acute‐on‐chronic liver failure in West Africa: a case–control study from The GambiaAlimentary Pharmacology & Therapeutics, 2015
- Phycocyanobilin accelerates liver regeneration and reduces mortality rate in carbon tetrachloride-induced liver injury miceWorld Journal of Gastroenterology, 2015
- Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injuryviaJNK-dependent mechanism in miceWorld Journal of Gastroenterology, 2015
- Mechanisms of fibrosis in acute liver failureLiver International, 2014
- Hepatitis E infection in patients with severe acute alcoholic hepatitisLiver International, 2014
- Acute Liver FailureNew England Journal of Medicine, 2013
- High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis ELiver International, 2013
- Influence of chronic HBV infection on superimposed acute hepatitis EWorld Journal of Gastroenterology, 2013
- NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?Nature Reviews Immunology, 2010